8
Growth Score in past quarter
pts
Heat Score 8 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Valevia developer antibacterial medications.
About the Company
The company was founded in 2009 as Valevia in Switzerland to develop antibacterial medications. AVX13616 (now VAL301) was licensed from the Australian drug development company Avexa . Subsequently, the company headquarters were moved to the UK in 2012 and was renamed Valevia UK. Valevia’s lead project is supported by a TSB feasibility grant, which
was awarded in 2013.